These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
91 related items for PubMed ID: 25123963
1. Molecular profiling in fresh tissue with high tumor cell content promotes enrichment for aggressive adenocarcinomas in cervix. Halle MK, Krakstad C, Engerud H, Bertelsen B, Salvesen HB. Pathol Res Pract; 2014 Nov; 210(11):774-8. PubMed ID: 25123963 [Abstract] [Full Text] [Related]
7. Expression of Twist enhances risk of poor oncologic outcome in patients with stage Ib to II cervical carcinoma with lymphovascular space involvement. Kajiyama H, Shibata K, Umezu T, Mizuno M, Suzuki S, Yamamoto E, Fujiwara S, Kikkawa F. Hum Pathol; 2013 Feb; 44(2):181-8. PubMed ID: 22974479 [Abstract] [Full Text] [Related]
9. p53 in surgically treated and pathologically staged cervical cancer: correlation with local tumor progression, but not with lymphatic spread. Horn LC, Fischer U, Hänel C, Kuhn H, Raptis G, Bilek K. Pathol Res Pract; 2001 Feb; 197(9):605-9. PubMed ID: 11569924 [Abstract] [Full Text] [Related]
10. The Prostaglandin EP3 Receptor Is an Independent Negative Prognostic Factor for Cervical Cancer Patients. Heidegger H, Dietlmeier S, Ye Y, Kuhn C, Vattai A, Aberl C, Jeschke U, Mahner S, Kost B. Int J Mol Sci; 2017 Jul 19; 18(7):. PubMed ID: 28753926 [Abstract] [Full Text] [Related]
11. Sonographic characteristics of squamous cell cancer and adenocarcinoma of the uterine cervix. Epstein E, Di Legge A, Måsbäck A, Lindqvist PG, Kannisto P, Testa AC. Ultrasound Obstet Gynecol; 2010 Oct 19; 36(4):512-6. PubMed ID: 20336641 [Abstract] [Full Text] [Related]
14. Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix. Juang CM, Wang PH, Yen MS, Lai CR, Ng HT, Yuan CC. Gynecol Oncol; 2000 Jan 19; 76(1):103-6. PubMed ID: 10620449 [Abstract] [Full Text] [Related]
15. [Expression of aquaporin-8 and bcl-2 protein in human cervical carcinoma and their correlations]. Yao JF, Zhou CY, Wei LF, Wang SY, Shi YF. Zhonghua Fu Chan Ke Za Zhi; 2008 Mar 19; 43(3):205-8. PubMed ID: 18788571 [Abstract] [Full Text] [Related]
17. The RASSF1A tumor suppressor gene is commonly inactivated in adenocarcinoma of the uterine cervix. Cohen Y, Singer G, Lavie O, Dong SM, Beller U, Sidransky D. Clin Cancer Res; 2003 Aug 01; 9(8):2981-4. PubMed ID: 12912945 [Abstract] [Full Text] [Related]
19. Expression of p16 protein and epidermal growth factor receptor in patients with adenocarcinoma of the uterine cervix: an immunohistochemical analysis. Bodner K, Laubichler P, Kimberger O, Czerwenka K, Zeillinger R, Bodner-Adler B. Arch Gynecol Obstet; 2011 Mar 01; 283(3):611-6. PubMed ID: 20405295 [Abstract] [Full Text] [Related]
20. The immune checkpoints CTLA-4 and PD-L1 in carcinomas of the uterine cervix. Karpathiou G, Chauleur C, Mobarki M, Peoc'h M. Pathol Res Pract; 2020 Jan 01; 216(1):152782. PubMed ID: 31862202 [Abstract] [Full Text] [Related] Page: [Next] [New Search]